Citation: | LIU Bowen, LIU Fulei, WANG Ruyi, XUE Jingwei, LIU Wenyuan, FENG Feng, QU Wei. Chemical constituents of total alkaloids from Picrasma quassioides and its effects on collagen induced arthritis in rats[J]. Journal of China Pharmaceutical University, 2019, 50(5): 585-592. DOI: 10.11665/j.issn.1000-5048.20190512 |
[1] |
Sapir-Koren R,Livshits G.Rheumatoid arthritis onset in postmenopausal women:Does the ACPA seropositive subset result from genetic effects,estrogen deficiency,skewed profile of CD4+ T-cells,and their interactions[J].Mol Cell Endocrinol,2016,431:145-163.
|
[2] |
McInnes IB,Schett G.The pathogenesis of rheumatoid arthritis[J].N Engl J Med,2011,365(23):2205-2219.
|
[3] |
Smolen JS, Steiner G. Therapeutic strategies for rheumatoid arthritis[J].Nat Rev Drug Discov,2003,2(6):473-488.
|
[4] |
Siebert S,Tsoukas A,Robertson J,et al.Cytokines as therapeutic targets in rheumatoid arthritis and other inflammatory diseases[J].Pharmacol Rev,2015,67(2):280-309.
|
[5] |
Baschant U,Lane NE,Tuckermann J.The multiple facets of glucocorticoid action in rheumatoid arthritis[J].Nat Rev Rheumatol,2012,8(11):645-655.
|
[6] |
Khan ZA,Tripathi R,Mishra B.Methotrexate:a detailed review on drug delivery and clinical aspects[J].Expert Opin Drug Deliv,2012,9(2):151-169.
|
[7] |
Smolen JS,Aletaha D,Koeller M,et al.New therapies for treatment of rheumatoid arthritis[J].Lancet,2007,370(9602):1861-1874.
|
[8] |
Lin QH,Xu J,Feng F.Chemical constituents from the stems of Picrasma quassioides Bennet[J].J China Pharm Univ(中国药科大学学报),2017,48(6):675-679.
|
[9] |
Han H,Zhang YY,Pan L,et al.Advances of active ingredients of traditional Chinese medicine in the prevention and treatment of osteoarthritis[J].J China Pharm Univ(中国药科大学学报),2018,49(3):279-285.
|
[10] |
Chinese Pharmacopoeia Commission.Chinese Pharmacopoeia:part 1(中华人民共和国药典:一部)[S].Beijing:China Medical Science Press,2015:200.
|
[11] |
Wang N, Li ZY, Zheng XL, et al. Quality assessment of Kumu injection,a traditional chinese medicine preparation,using hplc combined with chemometric methods and qualitative and quantitative analysis of multiple alkaloids by single marker[J].Molecules,2018,23(4):856-870.
|
[12] |
Jiao WH.Studies on Anti-inflammatory Constituents of Picrasma quassioides Bennt(中药苦木抗炎活性成分研究)[D].Shenyang:Shenyang Pharmaceutical University,2010.
|
[13] |
Jiang MX.Anti-tumor active ingredients and biotransformation of Picrasma quassioides Bennt(苦木抗肿瘤活性成分及生物转化研究)[D].Changsha:Central South University,2008.
|
[14] |
Zhao WN,Yu JJ,Su Q,et al.Antihypertensive effects of extract from Picrasma quassiodes(D.Don)Benn.in spontaneously hypertensive rats[J].J Ethnopharmacol,2013,145(1):187-192.
|
[15] |
Fan HY,Qi D,Yang MY,et al.In vitro and in vivo anti-inflammatory effects of 4-methoxy-5-hydroxycanthin-6-one,a natural alkaloid from Picrasma quassioides[J].Phytomedicine,2013,20(3/4):319-323.
|
[16] |
Chen L,Li JS,Ke X,et al.The therapeutic effects of Periploca forrestii Schltr.Stem extracts on collagen-induced arthritis by inhibiting the activation of Src/NF-κB signaling pathway in rats[J].J Ethnopharmacol,2017,202:12-19.
|
[17] |
Jia N,Chu W,Li YW,et al.Iridoid glycosides from the flowers of Gentiana macrophylla Pall.ameliorate collagen-induced arthritis in rats[J].J Ethnopharmacol,2016,189:1-9.
|
[18] |
Jiao WH,Gao H,Li CY,et al.Quassidines A-D,bis-β-carboline alkaloids from the stems of Picrasma quassioides[J].J Nat Prod,2010,73(2):167-171.
|
[19] |
Yang JS,Gong D.Kumujancine and Kumujanrine,two new β-carboline alkaloids from Picrasma quassioides(D.DON.)BENN.[J].Acta Chimica Sinica,1984,42:679-683.
|
[20] |
Liao HJ,Lai ZQ,Su JY,et al.Fingerprinting and simultaneous determination of alkaloids in Picrasma quassioides from different locations by high performance liquid chromatography with photodiode array detection[J].J Sep Sci,2012,35(17):2193-2202.
|
[21] |
Yang JS,Luo SR,Shen XL,et al.Chemical investigation of the alkaloids of Ku-mu[Picrasma quassioides(D.Don)Benn.][J].Acta Pharm Sin(药学学报),1979,14(3):167-177.
|
[22] |
Ohmoto T,Koike K.Studies on the constituents of Picrasma quassioides Bennet.I.On the alkaloidal constituents[J].Chem Pharm Bull,1982,30(4):1204-1209.
|
[23] |
Koike K,Ohmoto T.Studies on the alkaloids from Picrasma quassioides Bennet.VII.Structures of.BETA.-carboline dimer alkaloids,picrasidines-H and -R[J].Chem Pharm Bull,1986,34(5):2090-2093.
|
[24] |
Koike K,Ohmoto T.Studies on the alkaloids from Picrasma quassioides BENNET.IX.Structures of two.BETA.-carboline dimeric alkaloids,picrasidines-G and - S[J].Chem Pharm Bull,1987,35(8):3305-3308.
|
[25] |
Koike K,Ohmoto T,Ogata K.Studies on the alkaloids of Picrasma quassioides Bennet.VIII X-ray crystal structure analysis of picrasidine-F[J].Chem Pharm Bull,1986,34(8):3228-3236.
|
[26] |
Liang F,Li D,Wang RB,et al.Pharmacokinetics and absolute bioavailability of isoschaftoside in rat by LC-MS/MS[J].J China Pharm Univ(中国药科大学学报),2019,50(1):75-80.
|
[27] |
Firestein GS, McInnes IB. Immunopathogenesis of rheumatoid arthritis[J].Immunity,2017,46(2):183-196.
|
[1] | CHU Xuxin, BU Fanxue, YIN Tingjie, HUO Meirong. Antitumor strategies based on targeted modulation of tumor-associated macrophages[J]. Journal of China Pharmaceutical University, 2021, 52(3): 261-269. DOI: 10.11665/j.issn.1000-5048.20210301 |
[2] | FENG Yang, XU Xiao, MO Ran. Advances in lymphatic targeted drug delivery system for treatment of tumor metastasis[J]. Journal of China Pharmaceutical University, 2020, 51(4): 425-432. DOI: 10.11665/j.issn.1000-5048.20200406 |
[3] | TANG Keqin, LIN Huaqing, LI Shuhong, DONG Lixin, LU Bohong, JIANG Hong. Advances in tumor targeted nanocrystals[J]. Journal of China Pharmaceutical University, 2020, 51(4): 418-424. DOI: 10.11665/j.issn.1000-5048.20200405 |
[4] | SONG Ke, PAN Hao, HAN Jiayi, CHEN Lijiang. Nano drug delivery system based strategies to target tumor microenvironment[J]. Journal of China Pharmaceutical University, 2018, 49(4): 392-400. DOI: 10.11665/j.issn.1000-5048.20180402 |
[5] | CAI Han, LIU Yanhong, YIN Tingjie, ZHOU Jianping, HUO Meirong. Advances in the targeted therapy of tumor-associated fibroblasts[J]. Journal of China Pharmaceutical University, 2018, 49(1): 20-25. DOI: 10.11665/j.issn.1000-5048.20180103 |
[6] | WANG Letian, WANG Jinglin, LIU Hongwu, GE Ying, LI Yuyan, XU Qingxiang. Process in targeted contrast agents for cancer imaging[J]. Journal of China Pharmaceutical University, 2017, 48(6): 635-645. DOI: 10.11665/j.issn.1000-5048.20170602 |
[7] | SHANG Yunkai, JU Caoyun, XIE Daping, ZHANG Can. Preparation and characterization of tumor targeting doxorubicin liposomesmodified via click chemistry[J]. Journal of China Pharmaceutical University, 2016, 47(6): 708-713. DOI: 10.11665/j.issn.1000-5048.20160613 |
[8] | XU Yuhong, CAO Jing. Perspectives on targeted nano-drug carriers for tumor treatment[J]. Journal of China Pharmaceutical University, 2013, 44(6): 494-503. DOI: 10.11665/j.issn.1000-5048.20130602 |
[9] | SHI Yongping, SU Zhigui, XIAO Yanyu, SUN Minjie, PING Qineng, ZONG Li. Preparation and characterization of dual-targeting nanostructure lipid carriers loading mitoxantrone hydrochloride for bone tumor[J]. Journal of China Pharmaceutical University, 2013, 44(4): 321-327. DOI: 10.11665/j.issn.1000-5048.20130407 |
[10] | LI Sai, XIAO Yan-yu, SU Zhi-gui, SHI Lu, PING Qi-neng, ZHANG Can. Preparation of BSA-coated cationic nanostructure lipid carriers and pharmacokinetics and biodistribution after intravenous injection[J]. Journal of China Pharmaceutical University, 2012, 43(5): 406-411. |